Results for

""Ezetimibe, Simvastatin Drug Combination""[mesh_terms]

Pharmacokinetic drug evaluation of ezetimibe + simvastatin for the treatment of hypercholesterolemia.

Arrigo F G Cicero, Federica Fogacci, Marilisa Bove

Expert opinion on drug metabolism & toxicology 2017;13(10):1099-1104

Striated muscle safety of ezetimibe/simvastatin (Vytorin).

Darbie Maccubbin, Michael Stepanavage, John Strony, Michael H Davidson, Thomas Musliner

The American journal of cardiology 2006;97(2):223-8

Plant sterol supplementation on top of lipid-lowering therapies in familial hypercholesterolemia.

Maria C Izar, José M Santana, Sílvio A Barbosa, Waleria T Fonzar, Daniela T Malina, Henrique A Fonseca, Francisco A Fonseca, Valéria A Machado

International journal of cardiology 2016;184():570-572

Ezetimibe/statin combination therapy to treat patients with type 2 diabetes.

Michel Farnier

Atherosclerosis. Supplements 2015;17():2-8

Rationale and design of IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial): comparison of ezetimbe/simvastatin versus simvastatin monotherapy on cardiovascular outcomes in patients with acute coronary syndromes.

Christopher P Cannon, Robert P Giugliano, Michael A Blazing, Robert A Harrington, John L Peterson, Christine McCrary Sisk, John Strony, Thomas A Musliner, Carolyn H McCabe, Enrico Veltri, Eugene Braunwald, Robert M Califf

American heart journal 2009;156(5):826-32

Efficacy and safety of the coadministration of ezetimibe/simvastatin with fenofibrate in patients with mixed hyperlipidemia.

Michel Farnier, Eli Roth, Blas Gil-Extremera, Gustavo F Mendez, Geraldine Macdonell, Constance Hamlin, Inna Perevozskaya, Michael J Davies, Debra Kush, Yale B Mitchel

American heart journal 2007;153(2):335.e1-8

Reduction of ischemic events in Improved Reduction of Outcomes: Vytorin Efficacy International Trial: Intensive cholesterol lowering or ezetimibe antithrombotic effects?

Antonio Eduardo P Pesaro, Christopher B Granger, Renato D Lopes

American heart journal 2016;172():42-4

Benefit of Combination Ezetimibe/Simvastatin Among High-Risk Populations: Lessons from the IMPROVE-IT Trial.

Robert P Giugliano, Walter Oliver

Current atherosclerosis reports 2023;25(3):85-93

Aortic valvular stenosis: Novel therapeutic strategies.

Anetta Undas, Magdalena Kopytek, Joanna Natorska

European journal of clinical investigation 2021;51(7):e13527

Effect of ezetimibe and/or simvastatin on coenzyme Q10 levels in plasma: a randomised trial.

Ali Naini, Heiner K Berthold, Salvatore Di Mauro, Maarit Hallikainen, Helena Gylling, Wilhelm Krone, Ioanna Gouni-Berthold

Drug safety 2006;29(8):703-12

Ezetimibe--an update.

Drug and therapeutics bulletin 2009;47(8):91-5

Long-term efficacy and safety of ezetimibe/simvastatin coadministered with extended-release niacin in hyperlipidaemic patients with diabetes or metabolic syndrome.

S Fazio, J R Guyton, J Lin, J E Tomassini, A Shah, A M Tershakovec

Diabetes, obesity & metabolism 2011;12(11):983-93

Frequency and Impact of Hyponatremia on All-Cause Mortality in Patients With Aortic Stenosis.

Ahmad Sajadieh, Olav W Nielsen, Michael H Olsen, Ronnie Willenheimer, Steen Bendix Haugaard, Ronan M G Berg, Anders M Greve, Emilie Ramberg, Kristian Wachtell

The American journal of cardiology 2021;141():93-97

High-dose statin monotherapy versus low-dose statin/ezetimibe combination on fasting and postprandial lipids and endothelial function in obese patients with the metabolic syndrome: The PANACEA study.

Jan Westerink, John E Deanfield, Ben P Imholz, Wilko Spiering, Dick C Basart, Blai Coll, John J P Kastelein, Frank L J Visseren

Atherosclerosis 2013;227(1):118-24

Effects of Extended-Release Niacin Added to Simvastatin/Ezetimibe on Glucose and Insulin Values in AIM-HIGH.

Ronald B Goldberg, Debra L Simmons, Jennifer G Robinson, Ruth McBride, Lawrence A Leiter, John R Guyton, George Grunberger, Jerome L Fleg, Richard L Dunbar, Vera A Bittner, Carol Wysham, William E Boden, Ping Xu

The American journal of medicine 2017;129(7):753.e13-22